AbrahamJing-ChingWuMD

Gastrointestinal Cancer, Thoracic Cancer

Associate Attending

Overview of Dr. Wu

I am an academic radiation oncologist at Memorial Sloan Kettering Cancer Center, specializing in the treatment and research of gastrointestinal and lung cancers. I have particular expertise in stereotactic body radiotherapy for lung cancer, radiotherapy for esophageal cancer, and brachytherapy for thoracic and GI cancers. My clinical research is driven by practical questions and seeks to optimize radiation techniques, predict radiation outcomes, and prevent radiation toxicity. I also serve as the program director for MSKCC’s radiation oncology residency and have a keen interest in medical education.

Office
530 East 74th Street
New York, NY 10021
Book by Phone+1(260) 468-3113

Education & Training

Memorial Sloan Kettering Cancer CenterResidency, Radiation Oncology, 2006 - 2010
Virginia Mason Franciscan HealthInternship, Internal Medicine, 2005 - 2006
Harvard Medical SchoolClass of 2005

Certifications & Licensure

FL State Medical License 2022 - Present
NJ State Medical License 2021 - 2025
NY State Medical License 2006 - 2025
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

Educator of the Year Award Association for Residents in Radiation Oncology

Clinical Trials

Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung Cancer Start of enrollment: 2013 Jul 05
Active, not recruiting
Phase 1
Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer Start of enrollment: 2014 Feb 03
Active, not recruiting
Phase 3
Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management Start of enrollment: 2013 Nov 01
Active, not recruiting
Phase 2
Dose Escalation Trial of Endoluminal High-Dose-Rate Brachytherapy With Concurrent Chemotherapy for Rectal or Anal Cancer in Patients With Recurrent Disease or Undergoing Non-Operative Management Start of enrollment: 2014 Jul 01
Active, not recruiting
Phase 1
Local Therapies for Oligometastatic Non-Small Cell Lung Cancer Harboring Sensitizing EGFR Mutations Start of enrollment: 2015 May 14
Completed
Not Applicable
Intraoperative Radiation Therapy for Locally Advanced or Recurrent Abdomino-pelvic Solid Tumors With the CivaSheet Start of enrollment: 2016 Sep 01
Active, not recruiting
Phase 1
Durvalumab, an Anti-PDLI Antibody, and Tremelimumab, an Anti-CTLA4 Antibody, and Chemoradiation Before Surgery for Esophageal Cancer Start of enrollment: 2016 Nov 01
Recruiting
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

Association of the time of day of chemoradiotherapy and durvalumab with tumor control in lung cancer.
Matthew T McMillan, Annemarie Shepherd, Alissa J Cooper, Adam J Schoenfeld, Abraham J Wu
Radiotherapy and Oncology. 2024-12-01
Increased Occurrence of Malignancy Before and after Chemoradiation for Anal Squamous Cell Carcinoma: A Multi-Institutional Analysis.
Ritesh Kumar, Chris L Hallemeier, Daniel T Chang, Shou-En Lu, Lara Hathout
Journal of the National Cancer Institute. 2024-11-29
Esophagectomy may have a role in stage IV esophageal adenocarcinoma.
Marisa Sewell, Nicolas Toumbacaris, Kay See Tan, Nadia Bahadur, John Philip
The Journal of Thoracic and Cardiovascular Surgery. 2024-11-22

Journal Articles

Stereotactic Body Radiation Therapy (SBRT) Improves Local Control and Overall Survival Compared to Conventionally Fractionated Radiation for Stage I Non-Small Cell Lun...
Kenneth E Rosenzweig, Fauzia Shaikh, Daphna Y Gelblum, Shaun U Din, Andreas Rimner, Abraham J Wu, Acta Oncologica

Professional Memberships

American Society for Radiation Oncology
Member
International Association for the Study of Lung Cancer
Member
American Brachytherapy Society
Member

External Links

MSKCChttps://www.mskcc.org/cancer-care/doctors/abraham-wu

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Illinois PPO
Blue Shield California PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
GHI PPO
Great West PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Wellmark Alliance Select
Please verify your coverage with the provider's office directly when scheduling an appointment